Journal of Diabetes (Jul 2022)

成人1型糖尿病患者使用不同的连续血糖监测仪时血糖指标的差异

  • Yongwen Zhou,
  • Xiaodong Mai,
  • Hongrong Deng,
  • Daizhi Yang,
  • Mao Zheng,
  • Bin Huang,
  • Linlin Xu,
  • Jianping Weng,
  • Wen Xu,
  • Jinhua Yan

DOI
https://doi.org/10.1111/1753-0407.13296
Journal volume & issue
Vol. 14, no. 7
pp. 476 – 484

Abstract

Read online

Abstract Background Continuous glucose monitoring systems have been widely used but discrepancies among various brands of devices are rarely discussed. This study aimed to explore differences in glycemic metrics between FreeStyle Libre (FSL) and iPro2 among adults with type 1 diabetes mellitus (T1DM). Methods Participants with T1DM and glycosylated hemoglobin of 7%–10% were included and wore FSL and iPro2 for 2 weeks simultaneously. Datasets collected on the insertion and detachment day, and those with insufficient quantity (<90%) were excluded. Agreements of measurement accuracy and glycemic metrics were evaluated. Results A total of 40 498 paired data were included. Compared with the values from FSL, significantly higher median value was observed in iPro2 (147.6 [106.2, 192.6] vs. 144.0 [100.8, 192.6] mg/dl, p < 0.001) and the largest discordance was observed in hypoglycemic range (median absolute relative difference with iPro2 as reference value: 25.8% [10.8%, 42.1%]). Furthermore, significant differences in glycemic metrics between iPro2 and FSL were also observed in time in range (TIR) 70–180 mg/dl (TIR, 62.8 ± 12.4% vs. 58.8 ± 12.3%, p = 0.004), time spent below 70 mg/dl (4.4 [1.8, 10.9]% vs. 7.2 [5.4, 13.3]%, p < 0.001), time spent below 54 mg/dl (0.9 [0.3, 4.0]% vs. 2.6 [1.3, 5.6]%, p = 0.011), and coefficient of variation (CV, 38.7 ± 8.5% vs. 40.9 ± 9.3%, p = 0.017). Conclusions During 14 days of use, FSL and iPro2 provided different estimations on TIR, CV, and hypoglycemia‐related parameters, which needs to be considered when making clinical decisions and clinical trial designs.

Keywords